• Covid-19
  • Travel Protocols
  • Immigration & Customs Form
Wednesday, February 8, 2023
SKNIS
  • Home
  • About
  • Press Releases
  • Parliament
  • In The News
  • Bills
No Result
View All Result
SKNIS
No Result
View All Result
Home Featured

WHO statement on AstraZeneca COVID-19 vaccine safety signals

SKNISEditor by SKNISEditor
March 18, 2021
in Featured, Press Releases
WHO statement on AstraZeneca COVID-19 vaccine safety signals
Share on FacebookShare on Twitter

17 Mar 2021

Geneva, 17 March 2021 (WHO)—Some countries in the European Union have temporarily suspended use of the AstraZeneca COVID-19 vaccine as a precautionary measure based on reports of rare blood coagulation disorders in persons who had received the vaccine. Other countries in the EU—having considered the same information—have decided to continue using the vaccine in their immunization programmes.

Related posts

POST-CABINET BRIEFING FOR MONDAY, 9th JANUARY 2023

POST-CABINET BRIEFING FOR MONDAY, FEBRUARY 06, 2023

February 8, 2023
New Blood Bank Opening Hours, Campaign Launch Encourages Regular Blood Donation

New Blood Bank Opening Hours, Campaign Launch Encourages Regular Blood Donation

February 7, 2023

Vaccination against COVID-19 will not reduce illness or deaths from other causes. Thromboembolic events are known to occur frequently. Venous thromboembolism is the third most common cardiovascular disease globally.

In extensive vaccination campaigns, it is routine for countries to signal potential adverse events following immunization. This does not necessarily mean that the events are linked to vaccination itself, but it is good practice to investigate them. It also shows that the surveillance system works and that effective controls are in place.

WHO is in regular contact with the European Medicines Agency and regulators around the world for the latest information on COVID-19 vaccine safety. The WHO COVID-19 Subcommittee of the Global Advisory Committee on Vaccine Safety is carefully assessing the latest available safety data for the AstraZeneca vaccine. Once that review is completed, WHO will immediately communicate the findings to the public.

At this time, WHO considers that the benefits of the AstraZeneca vaccine outweigh its risks and recommends that vaccinations continue.

-30-

Previous Post

VISITORS CONVICTED FOR QUARANTINE BREACHES PAY FINE ALLOWED TO LEAVE

Next Post

AUTHORITIES STRONGLY ENCOURAGE BUSINESSES AND PROMOTERS TO SAVE CONTACT TRACING DATA FOR 30 DAYS

Next Post
AUTHORITIES STRONGLY ENCOURAGE BUSINESSES AND PROMOTERS TO SAVE CONTACT TRACING DATA FOR 30 DAYS

AUTHORITIES STRONGLY ENCOURAGE BUSINESSES AND PROMOTERS TO SAVE CONTACT TRACING DATA FOR 30 DAYS

WHAT'S HOT

POST-CABINET BRIEFING FOR MONDAY, 9th JANUARY 2023

POST-CABINET BRIEFING FOR MONDAY, FEBRUARY 06, 2023

February 8, 2023
New Blood Bank Opening Hours, Campaign Launch Encourages Regular Blood Donation

New Blood Bank Opening Hours, Campaign Launch Encourages Regular Blood Donation

February 7, 2023
Longstanding Debate on the Official St. Kitts and Nevis Coat of Arms Ends

New Blood Bank Opening Hours, Campaign Launch Encourages Regular Blood Donation

February 7, 2023

BROWSE BY CATEGORIES

  • Bills
  • Featured
  • In The News
  • Notices
  • Parliament
  • Press Releases
  • Register of Voters
  • Uncategorized

LIKE US ON FACEBOOK

Facebook Pagelike Widget

FOLLOW US

CATEGORIES

  • Bills
  • Featured
  • In The News
  • Notices
  • Parliament
  • Press Releases
  • Register of Voters
  • Uncategorized

CONTACT US

Government Headquarters
Church Street
Basseterre, Saint Kitts and Nevis 00265
(869) 467-1416

  • Government of St. Kitts & Nevis

© 2020 St. Kitts & Nevis Information Service. Developed by E-Government Unit

No Result
View All Result
  • Home

© 2020 St. Kitts & Nevis Information Service. Developed by E-Government Unit